Kisspeptin-10

Triggers the brain to release GnRH, which raises LH and FSH, which in turn raise testosterone (and estrogen). People run it for libido and arousal — the most-reported effect — and as a gentle push on natural testosterone and fertility, since it’s working with your own axis rather than overriding it. The honest catch: the acute hormone bump is well-documented, but the body-comp and libido protocols people actually run are not.

It sits at the very top of the chain. The erectile-dysfunction drugs work on blood flow; PT-141 works on the brain’s arousal pathway; kisspeptin works a step above even that, on the master switch that drives the whole hormonal cascade. There’s real human imaging behind the arousal angle — controlled fMRI work showing it modulates the brain’s sexual and emotional processing, not just hormone levels — which is rare for anything in this space. The flip side of being a switch: it’s built to be pulsed, and flooding the receptor continuously turns the signal off rather than up.

Binds the kisspeptin receptor (KISS1R) on GnRH neurons in the hypothalamus and drives them to release GnRH — the pulse that the pituitary reads as the command to secrete LH and FSH, which then tell the testes or ovaries to make testosterone or estrogen. GnRH neurons can’t sense sex-steroid feedback directly, so kisspeptin is the relay that carries that signal in; it’s genuinely the gatekeeper of the axis. Key pharmacology: the receptor desensitizes under continuous exposure (β-arrestin internalization), so a steady flood first stimulates and then suppresses GnRH — the opposite of what you want. The native peptide is also short-acting, which is why timing, not just dose, is the whole game.

In the controlled human studies the acute infusions were generally well-tolerated, with no consistent serious-side-effect signal — but those were short, supervised settings, not the repeated at-home dosing people actually run, so that clean record doesn’t fully transfer. The main practical caution is pharmacological rather than toxic: dose it continuously or too often and you desensitize the receptor, blunting your own axis instead of stimulating it. Because it raises the whole HPG cascade, it also lifts estrogen alongside testosterone, which is worth knowing for anyone sensitive to that. As always in this space, sourcing is unregulated — insist on a certificate of analysis before running anything.

There’s no canonical peptide stack here — it’s usually run on its own as an axis/libido nudge. Where it comes up alongside other compounds, it’s as an alternative philosophy to PT-141 (kisspeptin works upstream on the hormonal switch; PT-141 works on the brain’s arousal pathway directly) rather than a paired protocol. In clinical research it’s sometimes given with GnRH to probe the axis, but that’s a diagnostic setting, not a community routine.